Skip to main content Scroll Top

Fett Law Blog

McKesson's DEI Employment Practices: What the Company's Own Documents Show — and What They Mean for Employees

Between 2021 and 2024, McKesson Corporation published a numeric diversity goal in documents it filed with the Securities and Exchange Commission: a commitment to increase the representation of women and people of color in its vice-president-and-above leadership ranks by 20 percent by 2025, measured against fiscal 2021. The company tracked its progress against that goal in four consecutive annual reports and told shareholders that “progress is on track.” Setting demographic goals for business units was one of the four practices at the center of IBM's $17 million False Claims Act settlement with the U.S. Department of Justice in April 2026. Separately, in November 2024 a McKesson subsidiary agreed to pay $448,578 to resolve U.S. Department of Labor allegations of systemic hiring discrimination at a Texas distribution center, in a case the agency opened because of McKesson's contracts with the Department of Veterans Affairs.

Key facts

ItemDetail
CompanyMcKesson Corporation (NYSE: MCK), the Irving, Texas–headquartered pharmaceutical distributor and healthcare services company; fiscal year ends March 31. Total revenues of $403.4 billion in fiscal 2026; more than 43,000 employees worldwide, approximately 38,000 of them in the United States
Federal nexusSubstantial and documented. McKesson was selected in December 2019 as the prime pharmaceutical supplier to the Department of Veterans Affairs healthcare system. In November 2024 the U.S. Department of Labor stated that McKesson Medical-Surgical Inc. alone holds “more than $32 million” in federal contracts with the VA — the jurisdictional basis for a federal contractor compliance evaluation under Executive Order 11246
Documents reviewedCompany filings and publications, fiscal 2020–fiscal 2026: proxy statements (DEF 14A) filed June 2020 through June 2026; Forms 10-K for fiscal 2021 through fiscal 2026; the FY24 Impact Report; the company's current careers and impact pages; and the U.S. Department of Labor's November 2024 announcement
Practices documentedOne of the four IBM marker categories is documented in McKesson's own filings: numeric representation goals for leadership, published with baselines and tracked annually. A diverse-slate hiring requirement, a compensation link to demographic metrics, and race- or sex-restricted employee programs are not documented in McKesson's public record — each is addressed in its own section below, and each is answered honestly, including where the answer is no
Separate enforcement recordA November 4, 2024 conciliation agreement with the Department of Labor's Office of Federal Contract Compliance Programs resolving allegations of systemic hiring discrimination affecting 884 applicants at McKesson Medical-Surgical's Grapevine, Texas facility — $448,578 in back wages and interest plus 32 job offers. Allegations only; no finding of liability
Source-document statusThe core documents are permanent. The proxy statements and Forms 10-K carrying the goal, the baselines and the annual progress figures are filed with the SEC and remain publicly available on EDGAR regardless of what the company posts on its own website. The disclosures themselves stopped: the fiscal 2025 Form 10-K dropped the workforce diversity table and the phrase “people of color,” and the fiscal 2026 Form 10-K contains no workforce diversity content at all. The careers site is now titled “Inclusion & Belonging”

Did McKesson set racial or gender representation goals for its leadership ranks?

Yes, and it published them in filings with the Securities and Exchange Commission. McKesson Corporation told shareholders in its 2021 proxy statement that by 2025 it was striving to increase the representation of women and people of color in its leadership ranks — defined as vice president and above — by 20 percent compared with fiscal 2021. It published the fiscal 2021 baseline figures the goal was measured from, restated the goal in its 2022 proxy with the scope narrowed to women in North America and people of color in the United States, and reported progress against it in four consecutive annual reports.

The goal first appeared in the proxy statement McKesson filed on June 8, 2021, under the heading “Diversity, Equity and Inclusion”:

“By 2025, we are striving to increase representation of women and people of color amongst our leadership ranks by 20 percent as compared to FY 2021.” — McKesson Corporation, Proxy Statement (DEF 14A), filed June 8, 2021 (source)

The same document published the baseline. As of March 31, 2021, McKesson reported that women were 63% of its overall workforce and 35% of its leadership, and that people of color were 45% of its overall workforce and 21% of its leadership. Footnotes to that table defined “McKesson Leadership” as vice president level and above, “Women” as worldwide employees, and “People of Color” as U.S. employees only.

The 2022 proxy restated the goal with the populations defined more precisely, and told shareholders where the company stood:

“McKesson previously stated that by 2025, we would strive to increase representation of women across North America and people of color across the United States amongst our VP+ leadership ranks, each by 20% as compared to FY 2021.”

“The Company remains committed to these aspirational goals and we are encouraged that progress is on track.” — McKesson Corporation, Proxy Statement (DEF 14A), filed June 9, 2022, “Focus on People & Culture” (source)

The numbers behind the goal were published every year in McKesson's Form 10-K, the annual report it files with the SEC. The company disclosed the same two populations at the same two levels for four consecutive fiscal years, and then stopped:

As of March 31Women, overallWomen, VP+People of color, overallPeople of color, VP+
2021 (baseline)63%35%45%21%
202264%46%47%22%
202362%42%47%26%
202462%43%49%28%
2025Not disclosed — the workforce diversity table does not appear in the fiscal 2025 Form 10-K
2026Not disclosed — the fiscal 2026 Form 10-K contains no workforce diversity content

Figures as published by McKesson Corporation in its 2021 and 2022 proxy statements and its Forms 10-K for fiscal 2023 and fiscal 2024. The company's own footnotes vary year to year in how the populations are scoped — women worldwide or in North America, people of color in the United States only — and its fiscal 2021 metrics excluded employees of its US Oncology Network business because the data was not available. The figures should be read with those caveats, which are the company's own.

Read against the company's published baseline, the arithmetic of the goal is straightforward: a 20 percent increase over a fiscal 2021 starting point of 35% of VP+ roles held by women would put the target at roughly 42%, and a 20 percent increase over a starting point of 21% of VP+ roles held by people of color would put it at roughly 25%. McKesson's fiscal 2024 figures were 43% and 28%. We set out that comparison because it is arithmetic on the company's own published numbers, not because McKesson stated it in those terms.

What a goal of this kind means in practice depends entirely on how it was carried down. A published aspiration, standing alone, decides no individual case. What matters legally is whether a demographic target changed an actual employment decision — whether anyone was told to move a number, whether a promotion slate was managed to reach it, whether a business unit carried its own version of the target. The company's published documents do not answer those questions. The executives, HR leaders and people managers who worked inside the goal between 2021 and 2024 are the people who would know.

Did McKesson tie executive pay to diversity targets?

Not on the public record, and we will not say otherwise. Beginning in fiscal 2023, McKesson Corporation added a discretionary, downward-only “Sustainability Priority Areas” modifier to its management incentive plan, and the board committee that administers executive pay has express responsibility for overseeing diversity, equity and inclusion. But the company has never disclosed which priority areas the modifier actually measures, and no McKesson document we located states that representation metrics were among them. That is an open question, not a documented practice.

This section is included because the answer matters and because the honest answer is “undisclosed.” In the IBM matter, the Justice Department alleged the company used “a diversity modifier that tied bonus compensation to achieving demographic goals.” McKesson's public filings describe a modifier, but not its contents.

The mechanism was announced in the 2023 proxy statement:

“New for FY 2023: Sustainability Priority Areas — Ensures sustainability priorities are aligned with strategic business objectives and Company purpose — Discretionary Downward-Only Modifier”

“[W]e have incorporated considerations for key sustainability priority areas in our management incentive plan, designed to reinforce the importance of our values and drive accountability for sustainability initiatives.” — McKesson Corporation, Proxy Statement (DEF 14A), filed June 9, 2023 (source)

The same proxy describes the responsibilities of the board's Compensation and Talent Committee — the committee that sets executive pay — as including:

“Reviewing various sustainability matters relevant to the Committee's oversight responsibilities, including diversity, equity and inclusion, talent development, employee engagement and culture” — McKesson Corporation, Proxy Statement (DEF 14A), filed June 9, 2023 (source)

Those two disclosures sit next to each other: a pay committee expressly charged with overseeing diversity, equity and inclusion, and a pay modifier tied to unnamed “sustainability priority areas,” introduced in the same year, in the same document. They are not the same thing as a disclosed diversity metric in the incentive plan, and we do not present them as one. What they establish is that the question is a real one and that its answer lives in documents the public cannot see — the committee's materials, the scorecard behind the modifier, and any goal sheets that flowed down from it.

By the 2025 proxy statement the modifier had been renamed. It appears as “Non-Financial Priority Areas — Ensures progress on non-financial priorities that are aligned with our business strategy — Discretionary Downward-Only Modifier,” with the word “sustainability” removed and, again, no priority areas named.

Did McKesson require diverse slates in hiring and promotion?

Not on the public record. The phrase “diverse slate” does appear in McKesson Corporation's proxy statements filed in 2020, 2021, 2022 and 2023 — a full-text search of the company's SEC filings returns eight hits, all in proxy statements. In every instance the phrase describes the board's slate of nominees for election as directors, not a candidate pool for a job. We located no McKesson document imposing a diverse-slate or diverse-interview-panel requirement on employee hiring or promotion.

The distinction is worth stating precisely, because “diverse slate” is one of the four practices the Justice Department named in the IBM settlement and a search engine will match the phrase without regard to what it modifies. In McKesson's 2023 proxy the sentence reads: “We have a diverse slate of directors with broad and relevant leadership and professional experience.” The 2020 proxy uses it the same way, in the table of voting recommendations for the election of directors. That is a statement about the eleven people on the ballot, not about how the company filled its jobs.

Two things follow. First, a page that told you McKesson operated a diverse-slate hiring mandate would be wrong, and we are not going to tell you that. Second, the absence of a published requirement is not the same as the absence of a practice. Recruiting instructions, requisition workflows and hiring-manager guidance are internal documents; almost no company publishes them. If you worked in talent acquisition or as a hiring manager at McKesson while the leadership representation goal was in force, you would know whether anything of that kind existed, and the public record cannot tell you either way.

Did McKesson run programs restricted by race or sex?

Not on the public record, and the company's filings say the opposite. McKesson Corporation's fiscal 2025 Form 10-K states that each of its employee resource groups is “non-exclusive and open to every employee,” and its current careers site says the same. The one named program whose title refers to a protected characteristic is “Women in Leadership,” identified in the 2022 proxy as an employee development program; the company has not published its eligibility terms.

The Justice Department's allegations against IBM included training, mentoring and leadership development programs whose eligibility was “limited on the basis of race or sex.” McKesson's published descriptions do not match that pattern, and we state that plainly rather than stretch the record.

The company's fiscal 2025 annual report describes its employee resource groups this way:

“We also offer all employees the opportunity to join employee resource groups (‘ERGs’), which are voluntary, employee-led, company-sponsored networks that aim to make a positive impact on our employees' lives. Each ERG is non-exclusive and open to every employee.” — McKesson Corporation, Form 10-K for the fiscal year ended March 31, 2025, filed May 9, 2025, Item 1, Human Capital (source)

McKesson's careers site lists eleven such groups — among them Black Excellence, PALMa (Professional Association of Latinos), PAVE (Pan-Asian Voices for Excellence), MENA, Unity, Pride and Women Empowered — and states: “No matter your perspective or experience, each ERG is open to all employees.” Groups organized around identity but open to everyone are a materially different thing from programs with a race or sex eligibility screen, and the difference is the whole legal question.

On development programs, the 2022 proxy statement names two: “we have implemented employee development programs, including Amplify, a program designed specifically for McKesson's high potential talent, and Women in Leadership.” Amplify is described by performance, not by demographics. Women in Leadership is named for a protected characteristic, but McKesson has not published who was eligible to enter it, how participants were selected, or what it led to. Whether it operated as an open-enrollment program with a theme or as a selection channel restricted by sex is not something the public record answers — and it is exactly the kind of question a participant, a manager who nominated participants, or an employee who asked to join and was turned away would be able to answer.

What did the U.S. Department of Labor find about McKesson's hiring?

On November 4, 2024, the Department of Labor announced that McKesson Medical-Surgical Inc. had entered a conciliation agreement to resolve allegations of systemic hiring discrimination at its Grapevine, Texas distribution center. The company agreed to pay $448,578 in back wages and interest to 884 rejected applicants for associate material handler positions, to extend 32 job offers, to review its hiring procedures and to train management. The agency's jurisdiction came from McKesson Medical-Surgical's federal contracts with the Department of Veterans Affairs.

This is the one place in McKesson's record where a federal agency actually examined the company's hiring and reached a resolution. It is worth understanding precisely, because it is both narrower and more concrete than anything in the DEI disclosures above.

The Office of Federal Contract Compliance Programs — the Labor Department agency that audits federal contractors' employment practices — ran a compliance evaluation covering the period September 24, 2019 through September 24, 2021. According to the Department's announcement, the affected applicant group was made up of 472 Black, 226 Hispanic and 186 white applicants who were rejected for associate material handler roles. The agency's authority came from Executive Order 11246, which prohibits federal contractors from discriminating in employment, and it attached because, in the Department's words, McKesson Medical-Surgical holds “more than $32 million” in federal contracts with the Department of Veterans Affairs.

“Federal contractors must not engage in discriminatory hiring practices, it is the responsibility of the employer to ensure its selection practices comply with federal law.” — Ronald W. Sullivan II, Regional Director, Office of Federal Contract Compliance Programs, quoted in U.S. Department of Labor news release, November 4, 2024 (source)

Two points of accuracy. First, a conciliation agreement resolves allegations; it is not a finding that McKesson Medical-Surgical violated the law, and the company did not admit liability. Second, this matter is not a DEI case — the disfavored group spanned three racial categories, and the agency's concern was the selection procedure used to screen applicants for warehouse roles, not a diversity program. We include it because it establishes two facts that bear directly on everything above: McKesson entities are federal contractors subject to federal anti-discrimination obligations as a condition of getting paid, and the government has already looked at how one of them hires.

How McKesson's DEI disclosures changed, 2020–2026

DateDevelopment
June 18, 2020The proxy statement describes recruiting, developing and retaining “diverse talent” and a board commitment to elect an additional director by 2022 with attention to “Board diversity in terms of gender, ethnicity and skill”
June 8, 2021The proxy statement publishes the goal: “By 2025, we are striving to increase representation of women and people of color amongst our leadership ranks by 20 percent as compared to FY 2021,” with the fiscal 2021 baseline (women 63% overall / 35% VP+; people of color 45% overall / 21% VP+)
Sept. 24, 2019 – Sept. 24, 2021The period later covered by the Office of Federal Contract Compliance Programs' evaluation of McKesson Medical-Surgical's Grapevine, Texas hiring
June 9, 2022The proxy restates the goal for “VP+ leadership ranks,” scoped to women in North America and people of color in the United States, and reports that “progress is on track”
June 9, 2023A “Sustainability Priority Areas” discretionary downward-only modifier is added to the management incentive plan; the Compensation and Talent Committee's charter responsibilities expressly include “diversity, equity and inclusion.” The 20-percent goal is no longer restated in the proxy
May 8, 2024The fiscal 2024 Form 10-K publishes workforce diversity figures for the last time: women 62% overall / 43% VP+; people of color 49% overall / 28% VP+
Nov. 4, 2024The Department of Labor announces the $448,578 conciliation agreement with McKesson Medical-Surgical Inc. over alleged systemic hiring discrimination at Grapevine, Texas, resolving allegations affecting 884 applicants
Jan. 21, 2025Executive Order 14173 directs federal agencies to target DEI programs at federal contractors and requires contractor certifications regarding such programs
May 9, 2025The fiscal 2025 Form 10-K contains no workforce diversity table and does not use the phrase “people of color.” New language appears: the company seeks to attract and retain talent “while prioritizing recognition of merit and compliance with laws,” and each employee resource group is described as “non-exclusive and open to every employee”
2025The proxy statement renames the incentive modifier “Non-Financial Priority Areas.” The board states that it “does not maintain a formal policy regarding Board diversity”
May 8, 2026The fiscal 2026 Form 10-K contains no diversity content in its human capital disclosure at all — no workforce table, no employee-resource-group description, no reference to diversity, equity and inclusion
Aug. 2026McKesson's careers site is titled “Inclusion & Belonging.” The proxy statements and Forms 10-K containing the goal, the baselines and the annual progress figures remain permanently available on SEC EDGAR. Verified August 2026
Title VII of the Civil Rights Act of 1964 prohibits employment decisions made because of race or sex, and it protects every race and both sexes equally. A published representation goal is not itself unlawful. What the law examines is whether a protected characteristic sat inside an actual employment decision — whether a number to be moved became a reason someone was selected, or passed over.

Two recent Supreme Court decisions changed the landscape for these claims. In Muldrow v. City of St. Louis (2024), the Court held that an employee challenging a discriminatory job transfer need show only some harm to the terms or conditions of employment, not a “significant” disadvantage. In Ames v. Ohio Department of Youth Services (2025), a unanimous Court rejected the rule — previously applied in several federal circuits — that a majority-group plaintiff must produce extra “background circumstances” evidence before a discrimination claim can proceed. Separately, 42 U.S.C. § 1981 prohibits race discrimination in the making and enforcement of contracts, including employment relationships, and carries a four-year window with no agency filing requirement. (Title VII, 42 U.S.C. § 2000e-2.)

The False Claims Act route for federal contractors. On April 10, 2026, the U.S. Department of Justice announced that IBM would pay $17,077,043 to resolve False Claims Act allegations that it failed to comply with anti-discrimination requirements in its federal contracts — the first settlement under the DOJ's Civil Rights Fraud Initiative. In August 2026 the government resolved a second, larger matter: under a settlement agreement effective August 21, 2026, five Deloitte entities agreed to pay $21,500,000, of which $9,995,000 was restitution, covering conduct from January 1, 2017 through the settlement date. The certification hook is specific — Title VII as incorporated into federal contracts and FAR clause 52.222-26 — and the government's theory reached not only what Deloitte certified to its contracting agencies but what it “publicly represented” about its compliance. The agreement adds a second and independent theory: that Deloitte “allocated costs to its federal government contracts relating to these practices and sought payment and reimbursement under its federal government contracts for such costs.” The whistleblower was paid $4,300,000. Both settlements resolved allegations only, with no determination of liability, and Deloitte denies the conduct.

The practices the Justice Department identified in the IBM matter were a diversity modifier tying bonus compensation to demographic goals, “diverse interview slates,” race and sex demographic goals for business units, and programs whose eligibility was “limited on the basis of race or sex.” One of those four categories — numeric demographic goals — is described in McKesson's own SEC filings. On the government-business side, McKesson is the prime pharmaceutical supplier to the Department of Veterans Affairs healthcare system, and the Labor Department has stated that its medical-surgical subsidiary alone holds more than $32 million in VA contracts. Both routes matter here for the same reason: each depends on the company holding federal contracts, and each reaches conduct the company itself described in public documents.

To be clear about what is and is not established: no court or agency has found that McKesson's diversity goal violated any law; we located no reverse-discrimination lawsuit, EEOC action or False Claims Act matter arising from it; the November 2024 Labor Department agreement resolved allegations without any admission or finding of liability; and the IBM settlement likewise resolved allegations without any admission or determination of liability. What can be said is narrower and still worth knowing: McKesson published a numeric demographic target for its most senior ranks, tracked it publicly for four years, told shareholders it was on track, and did so while holding federal contracts that carry anti-discrimination obligations as a condition of payment. Practices in that category can give rise to liability under Title VII and § 1981 and, for federal contractors, potential False Claims Act exposure. For the complete framework — the four illegal DEI practice categories and when you can sue — see our guide, Is DEI Illegal? 4 Illegal DEI Practices & When You Can Sue.

Were you affected by these practices at McKesson?

If you worked at McKesson Corporation — or applied there — between 2021 and 2025, the record above may touch your situation in ways worth examining:

  • You were passed over for a promotion into or within the vice-president-and-above ranks during a period when the company had published a numeric target for increasing the share of those roles held by women and by people of color, and was reporting progress against it to shareholders.
  • You were a senior leader, HR business partner or talent-management professional who saw how the leadership representation goal was translated into instructions, scorecards, slates or targets below the executive level — the step the public documents do not describe.
  • You were an executive compensation, finance or governance professional with knowledge of what the “Sustainability Priority Areas” modifier actually measured in fiscal 2023 and after, and whether representation was among the priorities behind it.
  • You applied for an hourly warehouse or distribution role at a McKesson Medical-Surgical facility and were rejected — particularly at Grapevine, Texas between 2019 and 2021, the period the Labor Department examined.
  • You were told, or made to understand, that a role was reserved for a candidate of a particular race or sex, or that a hire or promotion was needed to move a number.

There is a separate question worth asking if your work touched McKesson's federal business. The False Claims Act's qui tam mechanism lets an individual bring a claim on the government's behalf, and potentially share in any recovery, where a company certified compliance with federal anti-discrimination requirements while doing something else — the theory the Justice Department used against IBM. Whether any McKesson entity made certifications of that kind during the relevant period is a fact-specific question the public record does not answer; it is the sort of thing an insider may know. Qui tam complaints are filed under seal, so a whistleblower's identity is initially protected. Both Title VII and the False Claims Act prohibit retaliation against people who assert their rights or report violations.

A federal settlement is not a substitute for your own claim: when the Justice Department resolved the Deloitte matter, it expressly preserved the EEOC's right to pursue charges alleging the very same conduct, and preserved individual liability. Nothing about that settlement compensated a single employee or applicant.

If any of these fits, it costs nothing to find out where you stand — meet our DEI discrimination lawyers, or start below.

Talk to an Employment Discrimination Lawyer

Start with a confidential intake — free evaluation, and if you have a potential claim, a free consultation in person or by Zoom, anywhere in the country. No fees unless the firm wins.

Start Your Confidential IntakeContact UsCall (734) 954-0100

Fett Law · 407 N. Main St., 2nd Floor, Ann Arbor, MI 48104 · attys@fettlaw.com

What could a claim against McKesson be worth?

Claims arising from practices like those described above can carry substantial value: False Claims Act whistleblowers receive 15–30% of any government recovery, individual discrimination cases combine uncapped lost pay with damages that several statutes leave uncapped, and a single companywide policy can support a class action. The figures below are illustrative — not a prediction for any individual case.

Whistleblower rewards under the False Claims Act

Under 31 U.S.C. § 3730(d), a qui tam relator receives 15–25% of the government's recovery when the Department of Justice intervenes, and 25–30% when the relator proceeds without intervention. The Deloitte settlement supplies a paid benchmark rather than a projection: the relator received $4,300,000 — exactly 20% of a $21,500,000 recovery. That settlement also shows why False Claims Act exposure outruns the money actually lost. Of the $21.5 million, $9,995,000 was restitution — roughly the government's single damages — so the resolution came to about 2.15 times the actual loss, because FCA recoveries are built on multiplied damages plus per-claim penalties. As a second illustration, arithmetic alone: an intervened case resolving at IBM's $17,077,043 would pay a relator roughly $2.6–$4.3 million. A contractor with a larger federal book or a longer conduct period could produce a materially larger number.

Damages in individual discrimination cases

Back pay and front pay are uncapped under Title VII. Compensatory and punitive damages under Title VII are capped by employer size — $300,000 for employers with more than 500 employees, the bracket McKesson occupies with more than 43,000 — but race claims under 42 U.S.C. § 1981 carry no damages caps at all, which is one reason race discrimination cases are often pleaded under it. Several state civil-rights statutes are likewise uncapped, including Michigan's Elliott-Larsen Civil Rights Act. Prevailing plaintiffs generally recover attorney's fees on top. For a sense of what employment discrimination cases can produce, Fett Law's own results include a $10.5 million race and age discrimination class action against Ford Motor Company, a $2 million disability harassment result, and a $1.6 million racially hostile work environment result. Prior results do not guarantee a similar outcome.

Class action potential

Class actions are built on a single policy applied to many people. A companywide numeric target for who holds the company's most senior roles is, by construction, a single policy — and the Labor Department's Grapevine matter shows what the other end of the workforce looks like when one selection procedure is applied to hundreds of applicants at a single facility. Historic employment-discrimination class settlements show the range such cases can reach: Coca-Cola paid $192.5 million (2000), Texaco $176.1 million (1996), and Novartis $175 million (2010) to resolve class claims.

Every case depends on its own facts — these figures show the range the law makes possible, not a promise of any outcome. The fastest way to learn where your situation falls is to start a confidential intake or request a free consultation.

Frequently asked questions

Is it illegal for McKesson to consider race or sex in hiring or promotions?

DEI programs are not illegal in themselves — “is DEI illegal” has no single answer. Title VII of the Civil Rights Act prohibits employment decisions made because of race or sex, and it protects employees of every race and both sexes equally. Whether any particular McKesson practice crossed the line depends on whether a protected characteristic actually changed a decision, which is fact-specific. No court has ruled that it did. See our full guide: Is DEI illegal? 4 illegal DEI practices & when you can sue.

What is a “DEI hire,” and is being called one a legal problem?

“DEI hire” is not a legal term — it is a label people apply when they suspect a hire was made because of a demographic characteristic rather than merit. It cuts both ways legally. Someone passed over may have a claim if race or sex actually drove the decision. Someone labeled a “DEI hire” by colleagues may have a harassment or hostile-work-environment claim if the label becomes persistent and severe. Both turn on evidence, not on the label.

Did McKesson set diversity targets for its leadership ranks?

Yes, on the company's own account. McKesson Corporation told shareholders in its 2021 proxy statement: “By 2025, we are striving to increase representation of women and people of color amongst our leadership ranks by 20 percent as compared to FY 2021.” Its 2022 proxy restated the goal for VP+ leadership ranks and reported that “progress is on track.” The goal no longer appears in McKesson's current filings.

Did McKesson require diverse candidate slates?

Not on the public record. The phrase “diverse slate” appears in McKesson Corporation's proxy statements for 2020 through 2023, but in every instance it describes the company's slate of nominees for election to the board of directors — not candidate slates for employee hiring or promotion. We located no McKesson document stating a diverse-slate or diverse-interview-panel requirement for jobs. We say so plainly rather than assume it.

What did the U.S. Department of Labor find about McKesson's hiring?

On November 4, 2024, the Department of Labor announced that McKesson Medical-Surgical Inc. agreed to pay $448,578 in back wages and interest and to extend 32 job offers to resolve allegations of systemic hiring discrimination affecting 884 applicants for associate material handler roles at its Grapevine, Texas facility. The agency's jurisdiction came from the company's federal contracts with the Department of Veterans Affairs. The agreement resolved allegations; there was no finding of liability.

How long do I have to file a discrimination claim?

Deadlines differ by claim and some are short. Under Title VII, the ADEA and the ADA you must file an EEOC charge within 180 days of the discriminatory act — extended to 300 days in states with their own fair-employment agency, which is most states — then sue within 90 days of a right-to-sue letter. A race claim under 42 U.S.C. § 1981 allows 4 years and requires no EEOC charge. A False Claims Act qui tam claim allows 6 years from the violation, or 3 years from when the government knew or should have known, capped at 10 years; FCA retaliation claims allow 3 years. The Equal Pay Act allows 2 years, or 3 if the violation was willful, and under the Ledbetter Act each discriminatory paycheck restarts the Title VII clock for pay claims. State law varies — Texas, where McKesson is headquartered, requires a charge with the Texas Workforce Commission Civil Rights Division within 180 days; Michigan's Elliott-Larsen Civil Rights Act allows 3 years with no agency filing. Deadlines are fact- and state-specific and waiting can forfeit a claim — contact us promptly to have your specific deadline assessed.

How far back can these claims go?

Even though McKesson removed this language from its filings, older conduct can still be actionable. Section 1981 reaches back 4 years; the False Claims Act can reach conduct up to 10 years back; and the continuing-violation doctrine and the Ledbetter paycheck rule can extend Title VII exposure for ongoing policies and their pay effects. Decisions made while the fiscal 2021 through fiscal 2024 goal was in force may therefore still be within reach today.

What if McKesson has already dropped these goals?

Dropping a goal does not erase decisions made while it was in force. Many companies changed or removed their diversity language during 2025; that shift does not undo a promotion, a hire or a leadership appointment that a representation target affected in 2022 or 2023. The claim belongs to the decision and is governed by the applicable filing deadline, not by whether the policy still exists today.

Did McKesson delete its DEI disclosures?

The disclosures stopped rather than disappeared. McKesson's Forms 10-K for fiscal 2021 through fiscal 2024 published a workforce table showing women and people of color overall and at VP+ level. The fiscal 2025 Form 10-K, filed May 9, 2025, contains no such table and does not use the phrase “people of color”; the fiscal 2026 Form 10-K contains no workforce diversity content at all. The earlier filings remain permanently available on SEC EDGAR. The company's careers site is now titled “Inclusion & Belonging.” Verified August 2026.

What is the IBM DEI settlement and why does it matter here?

On April 10, 2026, IBM paid $17,077,043 in the Justice Department's first False Claims Act settlement over allegedly discriminatory DEI practices, brought under the Civil Rights Fraud Initiative. The alleged practices included a diversity modifier on bonus pay, “diverse interview slates,” race and sex demographic goals for business units, and programs whose eligibility was limited on the basis of race or sex. It matters here because it is the template for how these claims are now brought against companies that sell to the federal government, and McKesson is a substantial federal contractor. Whether McKesson made certifications of the kind that theory depends on is a fact-specific question the public record does not settle.

Am I protected from retaliation if I come forward?

Yes. Title VII § 704(a) makes it unlawful to retaliate against an employee for opposing discrimination or filing a charge, and the False Claims Act's § 3730(h) separately protects whistleblowers from discharge, demotion and harassment. FCA qui tam complaints are filed under seal, so a whistleblower's identity is initially protected while the government investigates.

What if I signed an arbitration agreement or severance release?

These documents may limit some options, but they often do not bar everything. Releases cannot waive certain rights, arbitration clauses do not stop the EEOC or the Department of Justice from acting on their own authority, and some agreements are unenforceable as written. Bring the document to your consultation — its real effect needs professional review.

Sources

Links were checked in August 2026. SEC filings are permanently available on EDGAR.

  • McKesson Corporation, Proxy Statements (DEF 14A) — June 18, 2020 · June 8, 2021 (the 20-percent goal and fiscal 2021 baseline) · June 9, 2022 (goal restated; “progress is on track”) · June 9, 2023 (Sustainability Priority Areas modifier; Compensation and Talent Committee responsibilities)
  • McKesson Corporation, 2025 Proxy Statement — PDF (modifier renamed “Non-Financial Priority Areas”)
  • McKesson Corporation, Annual Reports on Form 10-K — fiscal 2022 · fiscal 2023 · fiscal 2024 · fiscal 2025 · fiscal 2026
  • U.S. Department of Labor, “McKesson Corp. subsidiary to pay $448K in back wages, interest to resolve alleged systemic racial hiring discrimination in Grapevine” (November 4, 2024) — news release
  • McKesson Corporation, “McKesson Selected by Department of Veterans Affairs as Prime Pharmaceutical Provider” (December 12, 2019) — press release
  • McKesson Corporation, “Inclusion & Belonging” careers page — current page; fiscal 2026 fourth-quarter and full-year results — earnings release
  • U.S. Department of Justice, “IBM Pays $17 Million to Resolve Allegations of Discrimination Through Illegal DEI Practices” (April 10, 2026) — press release
  • Settlement Agreement among the United States, Deloitte LLP, Deloitte Consulting LLP, Deloitte & Touche LLP, Deloitte Financial Advisory Services LLP, Deloitte Transactions and Business Analytics LLP, and the American Alliance for Equal Rights, effective August 21, 2026 (United States ex rel. American Alliance for Equal Rights v. Deloitte LLP, et al., No. 4:25-CV-458-O (N.D. Tex.)) — settlement amount, restitution allocation, relator share, covered period, Covered Conduct, and reserved claims
  • Title VII, 42 U.S.C. § 2000e-2 — statute; 42 U.S.C. § 1981 — statute; False Claims Act, 31 U.S.C. §§ 3729–3733 — statute; Ames v. Ohio Dep't of Youth Services, No. 23-1039 (June 5, 2025) — opinion
FL

About Fett Law
Fett Law represents employees nationwide in DEI discrimination and False Claims Act whistleblower cases — and was litigating DEI discrimination decades before it had a name. The firm's results include a $10.5 million race and age discrimination class action against Ford Motor Company, a $1.1 million jury judgment against the Michigan State Police, and a $460,000 reverse-discrimination settlement for three corrections officers. In November 2025, the firm filed Spilko v. Comerica (E.D. Mich.), a $30 million DEI discrimination lawsuit that drew national press coverage, and it has leveraged AI to assemble the documentary record on many of the Fortune 1000 companies. Fett Law's cases have been covered by CBS News, The New York Times, Fox News, and the New York Post. Consultations are free and confidential; representation is on contingency — no fees unless the firm wins. Meet our DEI discrimination lawyers →

Attorney Advertising.

This article is for informational purposes only and does not constitute legal advice. Reading it does not create an attorney-client relationship.

Quoted materials are drawn from McKesson Corporation's own published documents and public filings; characterizations of potential legal liability are opinion and do not assert that McKesson has been found to have violated any law. The November 2024 conciliation agreement between the Office of Federal Contract Compliance Programs and McKesson Medical-Surgical Inc. resolved allegations without any admission or finding of liability. The U.S. Department of Justice's April 2026 settlement with IBM and its August 2026 settlement with Deloitte each resolved allegations only, with no admission or determination of liability; Deloitte denies the Covered Conduct and denies the allegations in the underlying action. Litigation referenced on this page — including Spilko v. Comerica Management Co., Inc. (E.D. Mich.), in which Fett Law represents the plaintiff — consists of allegations that have not been proven. No statement on this page is a promise of any recovery or relator share in any particular case.

Prior results do not guarantee a similar outcome.

Published August 27, 2026 · Last updated August 27, 2026 · Fett Law, 407 N. Main St., 2nd Floor, Ann Arbor, MI 48104 · (734) 954-0100